Four-drug strategy reduces repeat miscarriages
<<   July/2006   >>
Sun Mon Tue Wed Thu Fri Sat
            1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31  

Arts
Movies
Humor
Television
Music

Business
Internet
Finance
Jobs
Investing
Economy

Computers
Software
Hardware
World
Mobile

Games
Video Games
RPGs

Health
Fitness
Medicine
Alternative

Home
Consumers
Cooking

Recreation
Travel
Food
Outdoors

Reference
Psychology
Science
Education

Regional
US
Canada
Europe

Science
NSF
Space
Technology

Society
People
Religion

Sports
Baseball
Soccer
Basketball
 
28/Jul/2006 8:45PM

NEW YORK (Reuters) -- For women who experience repeated unexplained miscarriages, the combination of prednisone, aspirin, folate, and progesterone increases their chances of having baby, a team of clinicians from Austria reports in the journal Fertility and Sterility.

Repeat or "recurrent" miscarriage is defined as at least three consecutive spontaneous pregnancy losses before 20 weeks of gestation. While higher maternal age, smoking, drinking, and other factors can raise the risk of miscarriage, oftentimes the cause is unknown.

Prednisone, aspirin, and progesterone have been reported to be effective in reducing recurrent unexplained miscarriage, Dr. Clemens B. Tempfer and colleagues at the University of Vienna School of Medicine point out, but combinations of these treatments have not been evaluated in clinical trials.

In their study, Tempfer's team treated 50 women with recurrent miscarriage with prednisone and progesterone for the first 12 weeks of gestation; aspirin for 38 weeks of gestation; and folate throughout their pregnancies.

They compared the clinical outcomes and side effects in these women with that of 52 untreated subjects of similar age and number of miscarriages.

Women treated with prednisone, progesterone, aspirin and folate had a considerably higher birth rate than untreated subjects, the investigators report. The overall birth rates were 77 and 35 percent, respectively.

The rates of first- and second-trimester miscarriage also favored the treatment group. Nineteen percent of treated women miscarried in the first trimester compared with 63 percent of comparison women. None of the treated women miscarried in the second trimester compared with 2 percent of untreated women.

"In addition, we did not note a higher rate of preterm birth or (fetal) growth restriction among the treatment group," Tempfer's team reports.

"Our data indicate that a combination of treatment consisting of high-dose, low-duration prednisone and aspirin, progesterone, and folate might be an effective treatment for women with (unexplained) recurrent miscarriage," the investigators conclude. They call for more trials to confirm these results.




Recent news in category
The joy of reading
Plan B advocates seek access for all
100-year-old: Try cold showers for long life

Global recent news
FRA - Shy and retiring Melain proud of trophy-laden career
Top 10 U.S. water parks
Reflections on Everest 2006

28/Jul/2006 8:32PM
NEW YORK (Reuters) -- Being overweight puts a greater burden on women's health than men's, a new study shows.

28/Jul/2006 7:58PM
MIAMI, Florida (AP) -- What can you do when the hurricane is long gone but the power is still out, and a glance into the pantry reveals paltry pickings: tins of tuna, a jar of olives, a can of green beans, some oil and vinegar?

28/Jul/2006 11:08AM
WASHINGTON (Reuters) -- People who ate a low-fat vegan diet, cutting out all meat and dairy, lowered their blood sugar more and lost more weight than people on a standard American Diabetes Association diet, researchers said this week.

28/Jul/2006 10:04AM
LONDON, England (CNN) -- A British company announced this week that it has developed the first effective small-dose bird flu vaccine.

27/Jul/2006 9:23PM
NEW YORK (AP) -- "I was SHOCKED to see a giant breast on the cover of your magazine," one person wrote. "I immediately turned the magazine face down," wrote another. "Gross," said a third.

Copyright © 2006 Rootio Ltd. All rights reserved.